Legendary Creatures (LEGN.US) Q1 revenue exceeded expectations, with CARVYKTI sales maintaining strong growth.

Wisdom Financial APP learned that Legend Biotech (LEGN.US) has released its financial performance for the first quarter. The data shows that Q1 revenue increased by 107.5% year-on-year to $195 million, exceeding expectations. Non-GAAP earnings per share were $0.07, better than expected.